Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...
German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger...
The Dutch start-up Ferr-Tech scored in all categories and with all jury members at the CHEManager Innovation Pitch 2022 and received the most votes overall.
In its third fundraising round in less than two years, Hong Kong-listed globally active CDMO giant GenScript Biotech has netted a fresh $224 million capital injection...
Indian drugmaker Sun Pharmaceutical Industries is to buy US biotech Concert Pharmaceuticals, gaining access to the latter’s lead product candidate deuruxolitinib for...
Bayer is increasingly shifting the commercial focus of its pharmaceutical business away from Europe and toward the US and China, Stefan Oelrich, head of the German group...
Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based...
Germany’s BioNTech said it plans to accelerate and broaden the clinical development of its cancer immunotherapy pipeline in the Asia-Pacific region by expanding its...
Amgen has agreed to buy Horizon Therapeutics for $28.3 billion including debt, boosting its portfolio of drugs for rare autoimmune and inflammatory diseases and beating...
Germany’s CropEnergies has given the go-ahead for its proposed 50,000 t/y renewable ethyl acetate plant to be built at the Zeitz Chemical and Industrial Park in Elseraue...
